| visit |
NOTES, |
NOTES: |
NOTES: e.g., Baseline, 6-Month Follow Up, Year 2 |
06/23/2025 13:26 PM
|
| src_subject_id |
ELEMENT_SIZE, |
ELEMENT_SIZE: 20 |
ELEMENT_SIZE: 45 |
05/13/2025 11:50 AM
|
| interview_age |
VALUE_RANGE, |
VALUE_RANGE: 0 :: 1260 |
VALUE_RANGE: 0::1440 |
04/04/2024 13:54 PM
|
| sex |
DESCRIPTION |
DESCRIPTION: Sex of the subject |
DESCRIPTION: Sex of subject at birth |
07/09/2021 10:38 AM
|
| interview_date |
NOTES, |
NOTES: Required field |
NOTES: |
01/08/2021 10:21 AM
|
| visit |
ELEMENT_SIZE, |
ELEMENT_SIZE: 50 |
ELEMENT_SIZE: 60 |
06/25/2020 10:25 AM
|
| sex |
VALUE_RANGE, , NOTES, |
VALUE_RANGE: M;F
NOTES: M = Male; F = Female |
VALUE_RANGE: M;F; O; NR
NOTES: M = Male; F = Female; O=Other; NR = Not reported |
02/21/2020 13:02 PM
|
| gender |
PERMANENTLY ALIASED |
gender |
sex |
04/22/2019 00:00 AM
|
| gender |
DESCRIPTION |
DESCRIPTION: Sex of the subject |
DESCRIPTION: Sex of the subject |
08/22/2018 10:43 AM
|
| gender |
DESCRIPTION |
DESCRIPTION: Block Brief 2000: Sex of the subject |
DESCRIPTION: Sex of the subject |
08/20/2018 10:21 AM
|
| gender |
DESCRIPTION |
DESCRIPTION: Sex of the subject |
DESCRIPTION: Block Brief 2000: Sex of the subject |
08/14/2018 16:18 PM
|
| visit |
NOTES, |
NOTES: Character description of each type of visit |
NOTES: |
07/18/2018 13:11 PM
|
| interview_date |
DESCRIPTION |
DESCRIPTION: Date on which the interview/genetic test/sampling/imaging was completed. MM/DD/YYYY |
DESCRIPTION: Date on which the interview/genetic test/sampling/imaging/biospecimen was completed. MM/DD/YYYY |
08/28/2017 15:10 PM
|
| visnum |
NOTES |
NOTES: -1.5 = Pre-Screening; -1 = Screening; 0 = Baseline; ## = Visit ## (from 1 to 10); Whole numbers = standard monthly visits; #.001 - #.009 = Unscheduled; #.1 = End of Phase 1; #.2 = End of Phase 2; #.3 = End of Phase 3; #.4 = End of Open Choice Phase; #.5 = End of Study; #.6 = Genetic Analysis; |
NOTES: -1.5 = Pre-Screening; -1 = Screening; 0 = Baseline; ## = Visit ## (from 1 to 10); Whole numbers = standard monthly visits; #.001 - #.009 = Unscheduled; #.1 = End of Phase 1; #.2 = End of Phase 2; #.3 = End of Phase 3; #.4 = End of Open Choice Phase; #.5 = End of Study; #.6 = Genetic Analysis; 1000=all visits |
12/05/2016 17:59 PM
|
| interview_date |
REQUIRED |
REQUIRED: Recommended |
REQUIRED: Required |
10/26/2016 14:54 PM
|
| interview_date |
REQUIRED |
REQUIRED: Required |
REQUIRED: Recommended |
10/26/2016 14:33 PM
|
| emd9 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|
| emd1 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|
| emd10 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|
| emd11 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|
| emd12 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|
| emd13 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|
| emd14 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|
| emd15 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|
| emd17 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|
| emd2 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|
| emd3 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|
| emd4 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|
| emd5 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|
| emd6 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|
| emd7 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|
| emd8 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|
| emd16 |
VALUE_RANGE |
VALUE_RANGE: 0::5; 10 |
VALUE_RANGE: 0::10 |
10/26/2016 10:59 AM
|